Kenichi Nakamura
Overview
Explore the profile of Kenichi Nakamura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
275
Citations
6470
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morohara K, Katsuno H, Endo T, Kikuchi K, Nakamura K, Matsuo K, et al.
Ann Coloproctol
. 2025 Mar;
41(1):97-103.
PMID: 40044114
No abstract available.
2.
Ando Y, Yanagisawa S, Ohno M, Kurihara H, Ito K, Ichimura M, et al.
Jpn J Clin Oncol
. 2025 Mar;
PMID: 40042578
Previously, we conducted the phase I study of 64Cu-ATSM, which is Cu-diacetyl-bis (N4-methylthiosemicarbazone) radiolabeled with Cu-64, for patients with brain tumors and determined the maximum tolerated dose. We started a...
3.
Shinomiya H, Matsuura K, Onimaru R, Ohkoshi A, Saito Y, Tachibana H, et al.
Int J Clin Oncol
. 2025 Feb;
30(3):489-496.
PMID: 39913014
Background: JCOG1212 is a dose-finding and efficacy confirmatory study of concurrent superselective intra-arterial infusion of cisplatin and radiotherapy (RADPLAT) for locally advanced primary squamous cell carcinoma of the maxillary sinus...
4.
Nakamura K, Koide T, Higashiguchi T, Matsuo K, Endo T, Kikuchi K, et al.
J Clin Med
. 2025 Jan;
13(24.
PMID: 39768742
In Japan, the hinotori™ surgical robot system (Medicaroid Corporation, Kobe, Japan) was approved for gastrointestinal surgeries in October 2022. This report details our initial experience performing liver resection using the...
5.
Tokura M, Ando M, Kojima Y, Kitadai R, Yazaki S, Atutubo C, et al.
Breast Cancer (Auckl)
. 2024 Nov;
18:11782234241288671.
PMID: 39493594
Background: Biomarkers to predict the recurrence risk are required to optimize perioperative treatment. Adjuvant chemotherapy for patients with human epidermal growth factor 2-positive (HER2-positive) early breast cancer is decided by...
6.
Nakagawa K, Watanabe S, Wakabayashi M, Yotsukura M, Mimae T, Hattori A, et al.
J Thorac Oncol
. 2024 Oct;
20(2):157-166.
PMID: 39395662
Introduction: The JCOG0802/WJOG4607L trial revealed superior overall survival in segmentectomy compared with lobectomy for small-peripheral NSCLC. Nevertheless, locoregional relapse (LR) is a major issue for segmentectomy. An ad hoc supplementary...
7.
Sasaki K, Mizusawa J, Bando H, Nakamura K, Kataoka T, Katayama H, et al.
Trials
. 2024 Oct;
25(1):665.
PMID: 39375801
Background: Poor patient accrual can delay reporting of clinical trials and, consequently, the development of new treatments. For reducing the risk of additional resource requirements, a method for setting planned...
8.
Yamamoto S, Kato K, Daiko H, Ito Y, Kajiwara T, Kojima T, et al.
Future Oncol
. 2024 Sep;
20(36):2849-2854.
PMID: 39331122
Treatment options for esophageal squamous cell carcinoma includes surgery and chemoradiotherapy (CRT), however there was limited information about the factors influenced in patients' decision-making. Patients who participated in JCOG0502, a...
9.
Hasuike S, Ozono Y, Uchida K, Ogawa S, Tamura H, Uchiyama N, et al.
Medicine (Baltimore)
. 2024 Sep;
103(22):e38383.
PMID: 39259089
Background: Nonalcoholic steatohepatitis (NASH) is an important etiology of hepatocellular carcinoma (HCC), and there is no established therapy for this syndrome. Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, autonomic dysregulation, and...
10.
Takashima A, Hamaguchi T, Mizusawa J, Nagashima F, Ando M, Ojima H, et al.
J Clin Oncol
. 2024 Aug;
42(33):3967-3976.
PMID: 39186709
Purpose: Doublet chemotherapy with fluoropyrimidine (FP) and oxaliplatin (OX) plus bevacizumab (BEV) is a standard regimen for unresectable metastatic colorectal cancer (MCRC). However, the efficacy of adding OX to FP...